Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,319 papers from all fields of science
Search
Sign In
Create Free Account
pediatric acute myeloblastic leukemia
Known as:
AML, childhood
, pediatric AGL
, AGL, pediatric
Expand
Acute myeloid leukemia occurring in childhood.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
AIE Regimen
Bone Marrow
Bone marrow stem cell
Cytarabine-Daunorubicin Regimen
Expand
Narrower (1)
childhood acute myeloblastic leukemia without maturation (M1)
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
The Impact of High Resolution Imaging on Diagnosis
A. Heidari
2016
Corpus ID: 78245786
Editor’s Note Pictorial representation of a subject enhances understanding. Graphical thinking enhances an individual’s memory…
Expand
Highly Cited
2011
Highly Cited
2011
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis
C. Cutler
,
K. Stevenson
,
+18 authors
K. Ballen
Bone Marrow Transplantation
2011
Corpus ID: 31302506
The main limitations to umbilical cord blood (UCB) transplantation (UCBT) in adults are delayed engraftment, poor immunological…
Expand
Review
2002
Review
2002
A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis
RG Ghalie
,
E. Mauch
,
+6 authors
DE Goodkin
Multiple Sclerosis
2002
Corpus ID: 11373100
To evaluate the incidence of therapy-related acute leukaemia (t-AL) after single-agent mitoxantrone (MITO) treatment, we reviewed…
Expand
Highly Cited
2001
Highly Cited
2001
Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation
E. Waller
,
H. Rosenthal
,
+6 authors
M. Boyer
2001
Corpus ID: 71451041
Relapse is the major cause of death after allogeneic bone marrow transplantation (BMT). This study tested the hypothesis that the…
Expand
Highly Cited
1996
Highly Cited
1996
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine
Sally P. Mossman
,
Françoise Bex
,
+11 authors
Edward A. Hoover
Journal of Virology
1996
Corpus ID: 43112683
Infection of pigtail macaques with SIVsmmPBj14, biological clone 3 (SIV-PBj14-bc13), produces an acute and usually fatal shock…
Expand
Highly Cited
1995
Highly Cited
1995
Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
H. Lawrence
,
G. Sauvageau
,
+5 authors
C. Largman
Experimental Hematology
1995
Corpus ID: 46039950
There is growing evidence that the HOX homeobox-containing transcription factors are differentially expressed during…
Expand
Highly Cited
1988
Highly Cited
1988
Morphologic, immunologic and cytogenetic (MIC) working classification of the acute myeloid leukaemias. Second MIC Cooperative Study Group.
H. Berghe
British Journal of Haematology
1988
Corpus ID: 30713948
Review
1982
Review
1982
Acute myeloid leukemia following treatment of hodgkin's disease. A review
Hans W. Grüunwald
,
F. Rosner
Cancer
1982
Corpus ID: 28082132
Risk factors were analyzed and searched for possible predictive parameters for the development of acute myeloid leukemia in 216…
Expand
Highly Cited
1982
Highly Cited
1982
Hyperthyroxinemia in patients with acute psychiatric disorders.
Daniel I. Spratt
,
Allan Pont
,
Myrna B Miller
,
I. Mcdougall
,
M. Bayer
,
William T. McLaughlin
American Journal of Medicine
1982
Corpus ID: 9028929
Review
1972
Review
1972
Acute myelocytic leukemia in adults
B. Clarkson
Cancer
1972
Corpus ID: 28734241
The proposed reasons why acute myelocytic leukemia (AML) is less responsive to chemotherapy than lymphoblastic leukemia are…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE